The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The beneficial effects of closed‐loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU‐WP10 trial
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-31
DOI
10.1111/dom.14654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- Prospective analysis of satisfaction and usability of closed-loop Diabeloop DBLHU treatment in patients with highly unstable type 1 diabetes
- (2021) Johanna Delagenière et al. ACTA DIABETOLOGICA
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed‐loop insulin delivery system: A series of N‐of‐1 randomized controlled trials
- (2020) Pierre‐Yves Benhamou et al. DIABETES OBESITY & METABOLISM
- Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp
- (2020) Katrin Nagl et al. PEDIATRIC DIABETES
- Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
- (2019) Stacey M. Anderson et al. Diabetes Technology & Therapeutics
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
- (2019) Emanuele Bosi et al. Lancet Diabetes & Endocrinology
- Advances in β-cell replacement therapy for the treatment of type 1 diabetes
- (2019) Marie-Christine Vantyghem et al. LANCET
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial
- (2018) Alexander Abitbol et al. Diabetes Technology & Therapeutics
- Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
- (2018) Lutz Heinemann et al. LANCET
- Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes
- (2018) Yoshifumi Saisho International Journal of Environmental Research and Public Health
- Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
- (2018) Sandrine Lablanche et al. Lancet Diabetes & Endocrinology
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia
- (2015) Pratik Choudhary et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More